Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Shock, Septic × Norepinephrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Shock, Septic 1 Hypotension 1

Interventions

Vasopressins 1 Norepinephrine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01718613 2018-05-18

VANCS II

Instituto do Cancer do Estado de São Paulo

Phase 3 Completed

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡